FDA Inspection
Novo Nordisk A/SNovo Nordisk A/S – FDA Inspection, Mar 25, 2024
Record Details
This FDA Inspection record concerns Novo Nordisk A/S, with an inspection on March 25, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Lindsey J. Brown (Issuing Officer)
- Ralph M. Bernstein
View Company Profile
ID · 06fe2bd0-d7e0-4521-9fdf-92aaf736552d
Inspection Facts
- Inspection number
- 1269488
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Novo Nordisk A/S
10| Date | Classification | Office | Project area |
|---|---|---|---|
| May 4, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2018 | Not classified | Office of Inspections and Investigations | |
| August 29, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S
- FDA Inspection 1209127 - 2023-05-04
- FDA Inspection 1230597 - 2022-12-02
- FDA Inspection 1107225 - 2019-09-06
- FDA Inspection 1044502 - 2018-03-07
- FDA Inspection 1028554 - 2017-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.